Whelan J - Search Results

1

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litière S, Hermans C, Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT; European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Judson I, et al. Among authors: whelan j. Lancet Oncol. 2014 Apr;15(4):415-23. doi: 10.1016/S1470-2045(14)70063-4. Epub 2014 Mar 5. Lancet Oncol. 2014. PMID: 24618336 Clinical Trial.

2

Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.

Strauss SJ, McTiernan A, Driver D, Hall-Craggs M, Sandison A, Cassoni AM, Kilby A, Michelagnoli M, Pringle J, Cobb J, Briggs T, Cannon S, Witt J, Whelan JS. Strauss SJ, et al. Among authors: whelan js. J Clin Oncol. 2003 Aug 1;21(15):2974-81. doi: 10.1200/JCO.2003.04.106. J Clin Oncol. 2003. PMID: 12885818

3

A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma.

McTiernan A, Meyer T, Michelagnoli MP, Lewis I, Whelan JS. McTiernan A, et al. Pediatr Blood Cancer. 2006 Mar;46(3):345-50. doi: 10.1002/pbc.20562. Pediatr Blood Cancer. 2006. PMID: 16206197 Clinical Trial.

4

High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours.

McTiernan A, Driver D, Michelagnoli MP, Kilby AM, Whelan JS. McTiernan A, et al. Among authors: whelan js. Ann Oncol. 2006 Aug;17(8):1301-5. doi: 10.1093/annonc/mdl108. Epub 2006 Jun 16. Ann Oncol. 2006. PMID: 16782749 Free article.

5

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, Hogendoorn PC, Memon MA, Weeden S, Uscinska BM, van Glabbeke M, Kirkpatrick A, Hauben EI, Craft AW, Taminiau AH; MRC BO06 and EORTC 80931 collaborators; European Osteosarcoma Intergroup. Lewis IJ, et al. Among authors: whelan j. J Natl Cancer Inst. 2007 Jan 17;99(2):112-28. doi: 10.1093/jnci/djk015. J Natl Cancer Inst. 2007. PMID: 17227995 Clinical Trial.

6

Experience of the use of trabectedin (ET-743, Yondelis) in 21 patients with pre-treated advanced sarcoma from a single centre.

Roylance R, Seddon B, McTiernan A, Sykes K, Daniels S, Whelan J. Roylance R, et al. Among authors: whelan j. Clin Oncol (R Coll Radiol). 2007 Oct;19(8):572-6. doi: 10.1016/j.clon.2007.05.006. Epub 2007 Jul 10. Clin Oncol (R Coll Radiol). 2007. PMID: 17624747 Clinical Trial.

7

Poor accrual of teenagers and young adults into clinical trials in the UK.

Whelan JS, Fern LA. Whelan JS, et al. Lancet Oncol. 2008 Apr;9(4):306-7. doi: 10.1016/S1470-2045(08)70080-9. Lancet Oncol. 2008. PMID: 18374282 No abstract available.

8

A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens.

Ray-Coquard I, Le Cesne A, Whelan JS, Schoffski P, Bui BN, Verweij J, Marreaud S, van Glabbeke M, Hogendoorn P, Blay JY. Ray-Coquard I, et al. Among authors: whelan js. Oncologist. 2008 Apr;13(4):467-73. doi: 10.1634/theoncologist.2008-0065. Oncologist. 2008. PMID: 18448563 Free article. Clinical Trial.

9

A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST).

Judson I, Leahy M, Whelan J, Lorigan P, Verrill M, Grimer R, Robinson M. Judson I, et al. Among authors: whelan j. Sarcoma. 2002;6(3):83-7. doi: 10.1080/1357714021000045217. Sarcoma. 2002. PMID: 18521337 Free PMC article.

10

Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials.

Gelderblom H, Jinks RC, Sydes M, Bramwell VH, van Glabbeke M, Grimer RJ, Hogendoorn PC, McTiernan A, Lewis IJ, Nooij MA, Taminiau AH, Whelan J; European Osteosarcoma Intergroup. Gelderblom H, et al. Among authors: whelan j. Eur J Cancer. 2011 Apr;47(6):895-902. doi: 10.1016/j.ejca.2010.11.036. Epub 2011 Jan 6. Eur J Cancer. 2011. PMID: 21216138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,136 results

Search Page